However, while waiting for further well-designed multicenter studies delineating the use of mTOR inhibitors, an attempt in implementing strategies to reduce CNIs in order to limit the impact of their exposure on cancer recurrence is reasonable [124]. This evidence concerns the gene MTOR and cancer.